Addus HomeCare (NASDAQ:ADUS) EVP Michael Wattenbarger Sells 300 Shares

Addus HomeCare Corporation (NASDAQ:ADUS) EVP Michael Wattenbarger sold 300 shares of the business’s stock in a transaction on Wednesday, February 25th. The stock was sold at an average price of $105.36, for a total transaction of $31,608.00. Following the completion of the sale, the executive vice president directly owned 9,444 shares in the company, valued at approximately $995,019.84. This represents a 3.08% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Addus HomeCare Stock Down 3.3%

Addus HomeCare stock traded down $3.58 during mid-day trading on Thursday, reaching $104.02. The company’s stock had a trading volume of 269,378 shares, compared to its average volume of 239,147. The company has a debt-to-equity ratio of 0.11, a quick ratio of 1.66 and a current ratio of 1.80. Addus HomeCare Corporation has a 12 month low of $88.96 and a 12 month high of $124.43. The business’s 50 day simple moving average is $109.57 and its 200 day simple moving average is $113.08. The company has a market capitalization of $1.92 billion, a price-to-earnings ratio of 19.97, a price-to-earnings-growth ratio of 1.26 and a beta of 0.91.

Institutional Investors Weigh In On Addus HomeCare

Several institutional investors have recently made changes to their positions in ADUS. Hohimer Wealth Management LLC raised its holdings in Addus HomeCare by 3.4% in the 3rd quarter. Hohimer Wealth Management LLC now owns 2,709 shares of the company’s stock valued at $320,000 after acquiring an additional 88 shares in the last quarter. Ameritas Investment Partners Inc. grew its holdings in shares of Addus HomeCare by 5.0% during the 2nd quarter. Ameritas Investment Partners Inc. now owns 1,854 shares of the company’s stock worth $214,000 after purchasing an additional 89 shares in the last quarter. Amalgamated Bank increased its position in shares of Addus HomeCare by 1.8% in the third quarter. Amalgamated Bank now owns 5,240 shares of the company’s stock worth $618,000 after purchasing an additional 93 shares during the period. Oregon Public Employees Retirement Fund raised its stake in Addus HomeCare by 2.5% in the fourth quarter. Oregon Public Employees Retirement Fund now owns 4,153 shares of the company’s stock valued at $446,000 after purchasing an additional 103 shares in the last quarter. Finally, GAMMA Investing LLC raised its stake in Addus HomeCare by 6.3% in the third quarter. GAMMA Investing LLC now owns 1,778 shares of the company’s stock valued at $210,000 after purchasing an additional 105 shares in the last quarter. 95.35% of the stock is currently owned by institutional investors.

Trending Headlines about Addus HomeCare

Here are the key news stories impacting Addus HomeCare this week:

• Positive Sentiment: Q4 earnings/earnings call emphasized continued revenue growth, margin-leverage opportunities and an M&A-driven growth strategy for 2026 — supports longer‑term earnings upside. Addus HomeCare Earnings Call Highlights Growth And Scale
• Positive Sentiment: Stephens trimmed its price target from $140 to $135 but kept an “overweight” rating — the new target implies meaningful upside from current levels, indicating analyst confidence in the company’s outlook despite the cut. Stephens price target note
• Neutral Sentiment: Addus will participate in the Raymond James Institutional Investors Conference (investor visibility event; typically neutral but can aid liquidity/coverage). Conference participation
• Neutral Sentiment: Some published short‑interest data in the feed shows zero shares (data glitch/inconsistent reporting across sources) — treat those specific zero figures with caution. MarketBeat ADUS page
• Negative Sentiment: Significant insider selling over Feb. 24–25: CEO R. Dirk Allison sold two blocks (4,988 and 2,364 shares) and multiple senior EVPs sold smaller blocks across the two days — coordinated insider sales can pressure sentiment even if individual sales are routine and pre‑planned. See CEO filing. CEO insider-sale SEC filing
• Negative Sentiment: Short interest rose earlier in February (as of Feb. 13 there were ~1.15M shares short, ~6.5% of shares outstanding and ~4.6 days‑to‑cover) — elevated short activity can amplify downward price moves. Short interest data

Analyst Ratings Changes

A number of research analysts have recently commented on the stock. Truist Financial set a $135.00 price objective on shares of Addus HomeCare and gave the company a “buy” rating in a research report on Wednesday, January 7th. Wall Street Zen upgraded Addus HomeCare from a “buy” rating to a “strong-buy” rating in a report on Monday. Weiss Ratings reissued a “hold (c+)” rating on shares of Addus HomeCare in a research report on Wednesday, January 21st. Stephens cut their price objective on Addus HomeCare from $140.00 to $135.00 and set an “overweight” rating for the company in a research report on Wednesday. Finally, BMO Capital Markets assumed coverage on Addus HomeCare in a research note on Thursday, November 13th. They set a “market perform” rating and a $120.00 target price for the company. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $134.33.

Addus HomeCare Company Profile

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.